182 related articles for article (PubMed ID: 19309718)
1. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
[TBL] [Abstract][Full Text] [Related]
2. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid changes in the excitatory amino acids concentration caused by the standard treatment of acute lymphoblastic leukaemia in children do not correlate with their later cognitive functioning.
Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Krawczuk-Rybak M; Braszko JJ
Neuropediatrics; 2009 Dec; 40(6):295-7. PubMed ID: 20446226
[TBL] [Abstract][Full Text] [Related]
4. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children.
Protas PT; Muszynska-Roslan K; Holownia A; Krawczuk-Rybak M; Braszko JJ
Pediatr Hematol Oncol; 2010 May; 27(4):306-13. PubMed ID: 20426521
[TBL] [Abstract][Full Text] [Related]
6. Intellectual functioning of childhood leukemia survivors--relation to Tau protein--a marker of white matter injury.
Krawczuk-Rybak M; Grabowska A; Protas PT; Muszynska-Roslan K; Holownia A; Braszko J
Adv Med Sci; 2012; 57(2):266-72. PubMed ID: 23154429
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia.
Van Gool SW; De Meyer G; Van de Voorde A; Vanmechelen E; Vanderstichele H
Neurotoxicology; 2004 Mar; 25(3):471-80. PubMed ID: 15019310
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol.
Holownia A; Trofimiuk E; Krawczuk-Rybak M; Jakubow P; Kaliszewski J; Muszynska-Roslan K; Braszko JJ
Acta Haematol; 2004; 112(4):222-4. PubMed ID: 15564737
[No Abstract] [Full Text] [Related]
9. Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study.
Jansen NC; Kingma A; Schuitema A; Bouma A; Huisman J; Veerman AJ; Kamps WA
Eur J Cancer; 2006 Nov; 42(16):2765-72. PubMed ID: 16935489
[TBL] [Abstract][Full Text] [Related]
10. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
[TBL] [Abstract][Full Text] [Related]
11. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
[TBL] [Abstract][Full Text] [Related]
12. No role for cerebrospinal fluid myelin basic protein levels in patients treated for childhood acute lymphoblastic leukemia.
Diezi M; Garcia E; Weid Nv; Beck-Popovic M
J Pediatr Hematol Oncol; 2009 Jun; 31(6):393-7. PubMed ID: 19648787
[TBL] [Abstract][Full Text] [Related]
13. Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy.
Peng CT; Wu KH; Lan SJ; Tsai JJ; Tsai FJ; Tsai CH
Eur J Cancer; 2005 May; 41(8):1158-63. PubMed ID: 15911239
[TBL] [Abstract][Full Text] [Related]
14. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
Jansen NC; Kingma A; Schuitema A; Bouma A; Veerman AJ; Kamps WA
J Clin Oncol; 2008 Jun; 26(18):3025-30. PubMed ID: 18565888
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid IL-6, TNF-α and MCP-1 in children with acute lymphoblastic leukaemia during chemotherapy.
Protas PT; Holownia A; Muszynska-Roslan K; Wielgat P; Krawczuk-Rybak M; Braszko JJ
Neuropediatrics; 2011 Dec; 42(6):254-6. PubMed ID: 22144012
[TBL] [Abstract][Full Text] [Related]
17. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
[TBL] [Abstract][Full Text] [Related]
18. Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.
Guo CY; Halton JM; Barr RD; Atkinson SA
Oncol Rep; 2004 Jan; 11(1):185-9. PubMed ID: 14654924
[TBL] [Abstract][Full Text] [Related]
19. Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia.
Swiatkiewicz V; Wysocki M; Odrowaz-Sypniewska G; Koltan A; Manysiak S; Dylewska K
Med Pediatr Oncol; 2003 Dec; 41(6):578-80. PubMed ID: 14595724
[No Abstract] [Full Text] [Related]
20. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment.
Janzen LA; Spiegler BJ
Dev Disabil Res Rev; 2008; 14(3):185-95. PubMed ID: 18924154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
